Diabetic macular edema: Evidence-based management
Year: 2018
Type: review
Abstract: Diabetic macular edema (DME) is the most common cause of vision loss in patients with diabetic retinopathy with an increasing prevalence tied to the global epidemic in type 2 diabetes mellitus. Its pathophysiology starts with decreased retinal oxygen tension that manifests as retinal capillary hyperpermeability and increased intravascular pressure mediated by vascular endothelial growth factor (VEGF) upregulation and retinal vascular autoregulation, respectively. Spectral domain optical coherence tomography (SD-OCT) is the cornerstone of clinical assessment of DME. The foundation of treatment is metabolic control of hyperglycemia and blood pressure. Specific ophthalmic treatments include intravitreal anti-VEGF drug injections, intravitreal corticosteroid injections, focal laser photocoagulation, and vitrectomy, but a substantial fraction of eyes respond incompletely to all of these modalities resulting in visual loss and disordered retinal structure and vasculature visible on SD-OCT and OCT angiography. Efforts to close the gap between the results of interventions within randomized clinical trials and in real-world contexts, and to reduce the cost of care increasingly occupy innovation in the social organization of ophthalmic care of DME. Pharmacologic research is exploring other biochemical pathways involved in retinal vascular homeostasis that may provide new points of intervention effective in those cases unresponsive to current treatments.
Source: Indian Journal of Ophthalmology
Authors: MichaelW Stewart, DavidJ Browning, Chong Lee
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Keywords: diabetic macular edema, diabetic retinopathy, type 2 diabetes, vascular endothelial growth factor, retinal oxygen tension, intravitreal anti-VEGF therapy, intravitreal corticosteroids, focal laser photocoagulation, vitrectomy, optical coherence tomography angiography, hyperglycemia management, blood pressure control, cost of care
Open Access status: diamond
OpenAlex ID: W2900925102
